Skip to content

Author

A. Zaniboni

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Oct 2026

Targeting RAS in pancreatic cancer.

Pancreatic ductal adenocarcinoma (PDAC) remains among the most lethal malignancies, and activating KRAS mutations occur in more than 90% of tumors. Direct RAS targeting has moved from proof of concept to randomized clinical benefit: in previously treated metastatic PDAC, daraxonrasib improved median overall survival, p...

F. Petrelli, L. Dottorini, A. Zaniboni · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.